HealthCare Global (HCG) reported a 13% YoY revenue increase in Q3 FY26, reaching INR 6,331mn. Excluding Milann, revenue also grew by 13%, driven by an 8% volume increase and a 5% ARPP increase. Adjusted EBITDA grew by 20% YoY to INR 1,108mn, with margin expansion. For 9MFY26, revenue reached INR 18,931mn, a 15% YoY increase.
Financial Performance
In Q3 FY26, HealthCare Global reported a revenue of INR 6,331mn, a 13% YoY increase. Excluding Milann, revenue grew by approximately 13%, driven by an 8% increase in volumes and a 5% increase in ARPP. The Adjusted EBITDA for Q3 FY26 was INR 1,108mn, a 20% YoY increase, with margins expanding due to operating leverage.
Cluster Performance
The West cluster saw the largest revenue growth at 17% YoY. The South cluster grew by 9% YoY despite some disruption in Andhra Pradesh. The East cluster reported a 13% YoY revenue increase, driven by higher growth from Ranchi. The International business grew by 42% YoY, reaching INR 157 Mn.
9MFY26 Results
For the nine-month period (9MFY26), HealthCare Global reported a revenue of INR 18,931mn, representing a 15% YoY increase. Adjusted EBITDA for the same period grew by 20%, reaching INR 3,458mn.
Key Operational Metrics
The ARPP for 9MFY26 stood at INR 83,684, a 3% YoY increase. The patient volume for 9MFY26 was 221k, a 13% YoY increase.
Strategic Developments
HCG is developing a greenfield hospital in North Bangalore. It will offer MR-LINAC technology. Operations are expected to commence by the end of Q4FY26 (Jan-Mar).
Source: BSE
